Darrow vs Pattern Data: how they compare in 2026

The models are the product and the agreement says so in terms. Section 8.3 states that the AI features are mandatory and integrated by default, and that a customer who does not accept the AI service providers' terms has no remedy other than to stop using the service. The published architecture is four layers of model work: ingesting raw signals at scale, interpreting them through legal context, reasoning across the result to prioritize and orchestrate action autonomously, and surfacing it to the teams responsible. Published throughput of more than 5 million signals detected monthly is not a volume a non-model system reaches. Remove the models and there is no product. Checked 4 September 2026.

The machine learning is the mechanism the buyer pays for. The product reads records, extracts exposure, injury and treatment data, scores every claimant against litigation criteria and auto-adjudicates eligible claims; remove the models and there is a docket spreadsheet. The company has sold nothing else since its founding and its litigation-specific models are the product it names. FAQ, platform page and home page read 6 September 2026.

Grounding is asserted without a mechanism a reader can inspect. The knowledge base is described in principle, connecting the laws that create obligations, the organisational weaknesses that emerge when they are not met, and the enforcement actions that follow, and the inputs are described by category as regulatory filings, incident reports, litigation patterns and market activity. Nothing describes how an output traces back to the signal that produced it: no citation, no source link, no retrieval method. Hallucination is addressed, but only as a disclaimer: section 8.3 records that generative AI involves uncertainties as to quality and accuracy and that the company has no control over output, and the trial terms disclaim liability for any undetected, misdetected or mischaracterised events, signals, risks or cases. No accuracy figure is published, no test set is described, and section 12.1 expressly disclaims any warranty of accuracy. The Research and Domain Coverage pages were not opened in this pass and are named here so the limit is visible.

Grounding is real and documented with sourcing, short of a first-party accuracy figure. The FAQ states the platform uses a retrieval-augmented generation approach over language models and that case reviewers validate AI-aggregated findings, the platform page states clear sourcing and human validation at every step and that every result can stand up to review, audit or settlement; a third-party review's ninety-eight percent accuracy figure is not credited. No first-party accuracy figure, test set or evaluation is published, and the primary-authority limbs do not apply to a record reader. FAQ, platform page and home page read 6 September 2026.

Autonomy is claimed in plain terms and oversight is asserted without a mechanism. The published description of the agentic layer says advanced AI systems reason across the intelligence, identifying emerging opportunities, prioritizing signals and orchestrating action autonomously, and the product is framed as an always-on legal red team. Against that, the only oversight statements are contractual disclaimers: section 8.3 provides that the customer is responsible for evaluating the results of its use of the AI features and that the service is not a substitute for legal advice, legal research and independent review. Nothing published describes what the system does unattended against what a person approves, no threshold is stated at which it escalates or stops, no review surface inside the portal is described, and nothing addresses what happens when a signal is wrong. Searched the home page and the terms of use on 4 September 2026; the platform, law firms and FAQ pages were not opened.

What runs alone, what a person must approve, and the threshold between them are published. Modes: the FAQ states that eligible claims are auto-adjudicated by the proprietary AI while complex or outlier cases are flagged for human review, and that case reviewers validate AI-aggregated findings; the home page states that every extraction, classification and score is built to support the team's review rather than bypass it. Threshold: eligibility and allocation logic set by the settlement criteria, recalculated when criteria change. Review surface: validated data, record status and what each case needs next, with sourcing on every result. Route back: flagged outliers go to a person. Nothing states a confidence level below which auto-adjudication is withheld beyond the criteria themselves. FAQ, platform page and home page read 6 September 2026.

Substantial deployment evidence, with the names and the numbers on opposite sides of the page. Roughly thirty customer organizations are shown by name, and they are serious ones in this market: Baron and Budd, Milberg, Girard Sharp, Bernstein Litowitz Berger and Grossmann, Zuckerman Spaeder, Singleton Schreiber, Kahn Swick and Foti, Lynch Carpenter, Bailey and Glasser, Nichols Kaster, Loevy and Loevy, Wolf Haldenstein, Stephan Zouras, Schneider Wallace, Freed Kanner, Kozyak Tropin and Throckmorton and Consovoy McCarthy, alongside Microsoft and Armis on the corporate side. Figures are published at corporate level: more than 22 billion dollars in legal exposure surfaced, over 80 organizations, more than 5 million signals detected monthly, over 22,000 legal professionals and more than 10,000 active matters. What is missing is the join between them. No figure is attached to any named firm, no case study is published, nothing is dated, and there is no testimonial from a named individual anywhere on the surfaces read.

Scale claims, unattributed figures and unnamed court appointments stand in for named deployments with figures. The FAQ states more than thirty litigations and 1.4 million cases on the platform, court-appointed roles in major settlement programs, settlement submissions in one day rather than fifteen and review costs cut by up to five times, none attributed to a named firm or program; home-page testimonials are unnamed; the chief executive's conference biography names the 3M Combat Arms Earplug and Philips CPAP litigations as deployments without figures. FAQ, home page and conference biography read 6 September 2026.

Nothing published addresses how client confidences are handled, and the terms that do exist run the other way. The confidentiality regime at section 11 defines Confidential Information as non-public business, product, technology and marketing information, and does not bring Customer Data within that definition, so the mutual confidentiality obligations do not by their terms reach what a customer puts into the service. Section 5.1 grants the company and its sub-processors an irrevocable, perpetual, sub-licensable license over Customer Data that expressly extends to training foundation models. Section 11.3 reserves a broad right to access, read, preserve and disclose any information obtained in connection with the service. Nothing addresses privilege or work product, nothing addresses segregation between customers or matters, and no retention period exists. What does exist is recorded for completeness: section 7.3 commits to reasonable industry-standard technical and organisational security measures to protect Customer Data, which is a security promise rather than a confidentiality one. Section 5.2 separately prohibits the customer from submitting protected health information.

Confidentiality is addressed at the level of general assurance. The FAQ states TLS encryption, HIPAA-compliant environments for protected health data, multi-factor authentication, stringent access controls and staff training; no customer agreement is published, so nothing binds a training position, and no statement on training use, retention, deletion, matter or docket segregation, third-party model providers, or privilege and work product was located. FAQ and platform page read 6 September 2026; the security page was not opened and is the rebuttal route.

A disclaimer exists inside the terms and the product surfaces do not address the question. Section 8.3 states that the customer acknowledges the service is not a substitute for legal advice, legal research and independent review, and the trial terms go further, adding that it is not a substitute for audit, assessment or any medical, legal or regulatory conclusion and that the customer is solely responsible for obtaining necessary legal, medical, scientific or regulatory advice and for its own due diligence. Both sit inside AI-features and warranty clauses rather than in a dedicated position. Nothing on the home page or the segment pages addresses the question at all. No competence or supervision language appears, no rule of professional conduct is named, and jurisdiction is handled by disclaimer rather than by limit, with section 12.1 disclaiming any guarantee that output is suitable for the customer's jurisdiction. The product recommends which matters a firm should pursue, which makes the absence of a supervision position more material than the disclaimer acknowledges.

No advice line or supervision statement was located. The product is sold to law firms and to court-appointed administrators, and the home page states the AI amplifies rather than replaces human judgment, which is a design statement rather than a position on where the lawyer's responsibility sits; no surface read states that outputs are not legal advice or how the product supports a supervising lawyer's duties, and no customer agreement exists to carry such a statement. Home page, FAQ and platform page read 6 September 2026.

No governance position is published for a system that decides which potential claims a firm sees. There is no responsible AI statement, no governance framework, no named owner accountable for model behavior, no description of pre-release evaluation, no published testing results, and nothing on bias, which matters unusually here because the system prioritizes signals and therefore determines which exposures surface and which do not. The company describes itself as an AI lab and publishes a Research page, which was not opened in this pass and is named here rather than credited, since a page title is not evidence of its contents. The agreement moves in the opposite direction, recording at section 8.3 that the company has no control over the output of the AI features. Searched the home page and the terms of use on 4 September 2026.

A design principle without a governance framework, testing regime or accountable owner. The home page states that the AI does not replace human judgment and that every output supports review, and the FAQ describes human-in-the-loop validation; no responsible AI framework, ISO 42001 or equivalent, pre-release testing results or statement about uneven output across litigations or record types is published on the surfaces read. Home page and FAQ read 6 September 2026.

A generic security clause covers the product without addressing what happens to customer content after processing. Section 7.3 commits to reasonable industry-standard technical and organisational security measures during the subscription term, with no control named: no encryption standard, no access model, no logging, no testing cadence. There is no security page anywhere in the site navigation or footer, which is itself unusual at this customer tier. Retention is not addressed at all and section 10.4 provides only that after termination the company may delete Customer Data, which is permissive and sits against the perpetual license granted at section 5.1. Sub-processors are acknowledged to exist at section 8.1 and none is named. No incident or breach notification practice was located. The privacy policy is incorporated by reference at section 7.1 and was not opened in this pass; section 7.1 is headed Privacy Policy and DPA but no data processing agreement is linked or published.

Some of the ground is covered. Access control: TLS in transit, HIPAA-compliant storage for protected health data, multi-factor authentication, stringent access controls and continuous staff training, with adherence to SOC 2 and regular audits stated. Not located: a retention period, a deletion commitment, a sub-processor list or an incident-notification practice; no customer agreement is published and the security and privacy pages were not opened and are the rebuttal route. FAQ read 6 September 2026.

A real published position, short of the full picture. Section 14.1 gives a company indemnity, narrow but genuine, covering third-party claims that the grant of the right to use the service infringes a valid United States patent, with five named exclusions and remedies at section 6.4, and the agreement states expressly that these are the sole and entire liability and exclusive remedy for intellectual property infringement. Section 13 caps aggregate liability at fees paid in the preceding twelve months, dropping to 50 US dollars for trial and pre-released services under section 2.3 and for the drug and device intelligence trial. What is absent is any warranty a buyer could invoke: section 12.1 disclaims accuracy, completeness, availability and security outright, section 8.3 states the company shall not be liable for the performance of the AI features and does not guarantee the accuracy or reliability of any output, and the trial terms disclaim liability for undetected or mischaracterised signals, risks or cases. No insurance position was located.

No liability position is published. The site's page inventory, taken from the navigation and footer on 6 September 2026, carries Privacy, Security, Careers and an AI-search page and no terms of service or customer agreement; the FAQ describes pricing as tailored per firm, which places the agreement in a negotiated document the vendor does not publish. This is an absence on the vendor's surfaces rather than a retrieval limit. FAQ and footer read 6 September 2026.

No integration into practice systems was located. Section 8.4 of the agreement refers to integration with certain third-party applications as set forth in the company's documentation or within the service, and then spends the rest of the clause disclaiming responsibility for them, without naming a single one. No case management system, document management system, intake platform or CRM appears anywhere on the surfaces read, and there is no integrations page or developer documentation in the navigation or footer. This matters for the buyer segment named first on the site, since a plaintiff firm receiving case signals needs them to land in an intake or matter system. The Platform and Law Firms pages were not opened in this pass and are named here so the limit is visible. Checked 4 September 2026.

Real integrations with depth described for one. The navigation carries an Integrations page and a dedicated Litify page, the FAQ states an open API with customizable scripts for automated actions, bulk imports from cloud storage systems and drag-and-drop upload, and the FAQ describes integration with existing case management systems; the platform page states that settlement packets are generated in the formats claims administrators require. The Integrations and Litify pages were not opened, so what syncs with Litify and in which direction is not recorded. FAQ, navigation and platform page read 6 September 2026.

Nothing is published about where the software runs or where customer content sits. No region, country, hosting provider or data center is named on any surface, and no tenancy model is described: nothing states whether the platform is single or multi-tenant or how one customer's data is separated from another's. The agreement says only, at section 8.1, that the service is hosted and made available by certain sub-processors, none of them named. No deployment option, private tier or residency commitment of any kind is offered. The one geographic signal is indirect, in the export control clause at section 15.1 referring to Israeli, United States or foreign export controls. Searched the home page, the terms of use, the site navigation and the footer on 4 September 2026.

Cloud delivery is stated and neither tenancy nor region is addressed. The FAQ states storage of protected health data in secure HIPAA-compliant environments and bulk import from cloud storage, and no hosting provider, region, residency option or tenancy model is named on the surfaces read; the security page was not opened and is the rebuttal route. FAQ read 6 September 2026.

No independent security attestation was located. No SOC 2, ISO 27001, HIPAA or any other framework is claimed anywhere, no auditor or certifying body is named, no report is offered at any access tier, and no penetration testing is mentioned. There is no security page and no trust center: the site navigation carries Law Firms, Insurance, Compliance, Research and a Company menu, and the footer carries only a cookie policy, a privacy policy and the terms of use. The agreement offers section 7.3 alone, promising reasonable industry-standard measures without naming a standard. There are no unsupported badges on display either, which is why this sits at the floor on absence rather than on overclaiming. Checked home page, terms of use, site navigation and footer on 4 September 2026.

A standard is referred to without an attestation on the surfaces read. The FAQ states adherence to SOC 2 compliance and regular comprehensive security audits and full HIPAA compliance, which is a compliance claim rather than a statement that a SOC 2 report has been issued; no report type, auditor, coverage period or route to a report is stated, and the Security page in the footer was not opened and is the rebuttal route to B. FAQ read 6 September 2026.

Partial disclosure, with the providers named and change notification expressly refused. Section 8.3 identifies the AI service providers as third parties including Anthropic Claude and OpenAI, both rendered with spelling errors in the published text, and makes clear that the AI features are mandatory and integrated by default. That is more than most records in this corpus publish, and it appears in the agreement rather than in marketing. The same clause then removes the second limb: the company reserves the right to use different AI service providers at any time without providing prior notice, and a customer who objects to a current or future provider has no remedy but to stop using the service. The word including leaves the list non-exhaustive. No specific model or version is named, no location is given for inference, and no subprocessor list is published, with section 8.1 acknowledging sub-processors without identifying any.

The vendor describes its architecture without identifying what sits underneath. The FAQ states a retrieval-augmented generation approach and large language models, and the litigation pages describe models tailored to specific litigations; no provider, model, inference location or change-notification commitment is named on the surfaces read. The security page is the rebuttal route. FAQ and platform page read 6 September 2026.

No pricing information is published at any level, including the unit of charge. There is no pricing page in the navigation or the footer, no tier names, no feature split, no indication of whether charging is per user, per matter, per signal or per case, and no free trial or self-serve route. Every call to action resolves to requesting a demo, talking to the team or booking time. What the agreement reveals is the shape of the arrangement rather than its price: fees are set in an Order Form, stated in US dollars, payable annually in advance, non-cancelable and non-refundable, with automatic renewal unless canceled 30 days before expiry and overage fees for excessive use. A banner stating that 78 percent of production is already reserved suggests a capacity-constrained commercial model, which makes the absence of any published unit more significant rather than less. No VendorPricing row is written.

The unit and structure are stated without the figure. The FAQ describes a transactional pricing model with fees based on case volume and the specific services used, naming case analysis, settlement award allocation and settlement packet generation as priced services, tailored per firm to caseload and budget, and claims review fees cut by up to five times against manual review; no figure, rate card or pricing page is published. FAQ read 6 September 2026.

Segment coverage is described with substance across three distinct buyers and the boundaries are left open. Each segment carries its own page and its own stated job: law firms identifying emerging litigation earlier and building case portfolios, insurers detecting exposure and pricing risk, and corporate compliance teams surfacing exposure across their external digital footprint. That is an unusually clear statement of who the product is for. Practice breadth is quantified as more than 50 legal exposure categories covered, and a Domain Coverage page exists in the footer, which was not opened in this pass. The named customer set corroborates the primary segment, being overwhelmingly plaintiff and class action firms. What is missing is the edge: no individual practice area is named on the surfaces read, no firm size is addressed, no jurisdiction of coverage is stated, and nothing says which exposure types or industries fall outside the system.

Segment and coverage are described with substance and the boundary is the product's stated scope. Buyers are plaintiff firms, defense firms, settlement administrators and special masters; the litigation pages name Roundup, AFFF and PFAS, Camp Lejeune, Depo-Provera, hair relaxer, GLP-1, Paraquat, social media, talc and Zantac, with more than thirty litigations supported; the vendor states the platform is purpose-built for mass tort and multidistrict litigation, which is the limit. No jurisdiction outside the United States is addressed. Navigation, FAQ and platform page read 6 September 2026.